Thermo Fisher Scientific, LIMS & Laboratory Software news
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of its collaboration with My Green Lab, a non-profit organization committed to improving the environmental sustainability of scientific research. The company has set a goal to obtain
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.26 per common share, payable on October 15, 2021, to shareholders of record as of September 15, 2021.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in
The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific`s Applied Biosystems RapidHIT ID DNA Booking System for use by law enforcement booking stations to automatically process, upload and search DNA reference samples from qualifying arrestees against the U.S. National DNA Index System (NDIS) CODIS database.
The RapidHIT ID DNA Booking System is a fully automated, sample-to-answer genetic analyzer, allowing for an arrestee DNA sample to be processed,
Thermo Fisher Scientific, (NYSE: TMO) the world leader in serving science, and the University of California, Davis (UC Davis) West Coast Metabolomics Center today announced The Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations, best practices and standard operating procedures to support the rapid scale-up of large cohort studies and
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2021 before the market opens on Wednesday, July 28, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.
During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 714-0931 with
Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. This grant aims to provide funding for high-quality molecular profiling studies focusing on the impact of immune-based treatments for
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT).
You can access the webcast of the presentation via t
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer that combines acoustic focusing flow cytometry technology with a high-speed camera. The Attune CytPix allows users to collect high-performance fluorescent flow cytometry data from cells while simultaneously capturing high resolution brightfield images, allowing users to match images with their flow cytometry data to b
Scientists within academia and industries including pharmaceutical, biopharmaceutical and food and beverage analysis, can now benefit from new and improved software capabilities to enhance productivity and usability. The latest software updates enable more strength and flexibility in laboratory workflows in numerous fields, including biotherapeutic characterization, metabolomics and forensic analysis—providing users with intelligent data acquisition and increased confidence in results.<
Thermo Fisher Scientific, the world leader in serving science, and Newomics a commercial-stage biotechnology company, are collaborating to develop a novel native liquid chromatography-mass spectrometry (LC−MS) platform to support various LC−MS applications. This agreement utilizes Newomics` experience in creating innovative and integrative platforms and solutions for precision medicine and Thermo Fisher`s cutting-edge LC-MS systems